RT @SABOURETCardio
This confirms that work in patients "the higher is the baseline risk, the higher are the benefits" (as usual) academic.oup.com/ehjcvp/advanc

#pcsk9i #ma #T2D #lipids

Last updated 1 year ago

RT @SABOURETCardio
Few events, p=0.047 but data which reinforce that very low after is safe and associated with further reduction of academic.oup.com/eurheartj/adv

#ldl #acs #mace #llt #pcsk9i

Last updated 1 year ago